Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Antiemetics × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplastic Cells, Circulating 1 Metastatic Neuroendocrine Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Blood Specimen Collection 6 cabazitaxel 3 Anesthesia, General 2 Leukapheresis 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Docetaxel 1 Data Collection 1 Antiemetics 1 Anesthesia, Spinal 1 Analgesia, Epidural 1 Adrenal Cortex Hormones 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03050866 2021-08-20

CABA-V7

Erasmus Medical Center

Phase 2 Unknown

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡